Summary Objective: Considering the importance of screening for prostate cancer, the possibility of damage resulting from indiscriminate screening and the difficulty of disclosure and adherence to the main guidelines on the subject, we aimed to identify current guidelines, look for common approaches and establish a core of conducts. Method: Systematic review of the literature on screening practice guidelines for prostate cancer searching the databases PubMed, Lilacs and Google Scholar and active search in the sites of several national health entities. Results: Twelve (12) guidelines were selected, whose analysis resulted in the identification of six common points of conduct, with the following minimum core of recommendations: (1) screenin...
Whether to screen for prostate cancer in aging men is a topic that is fairly well researched, but re...
Introducing screening for prostate cancer requires evidence that this would do more good than harm. ...
What is the role of prostate-specific antigen (PSA) screening in prostate cancer? An expert panel pr...
OBJECTIVES: To review evidence regarding the potential introduction of prostate cancer screening pro...
men. It rarely causes death in men younger than 50 years; most deaths associated with it occur in me...
Background Prostate-specific antigen (PSA) remains as the most used biomarker in the detection of ea...
In 2009, the American Cancer Society (ACS) Prostate Cancer Advisory Committee began the process of a...
Since 2012, multiple new guidelines have been issued advising changes in screening for prostate canc...
Objective To investigate the efficacy and safety of prostate-specific antigen (PSA) testing to scree...
Since the early 1990s, many variants of the tPSA assay have been introduced to increase the sensitiv...
OBJECTIVES: To develop clinical guidelines for the management of patients with prostate cancer. MET...
What is the role of prostate-specific antigen (PSA) screening in prostate cancer? An expert panel pr...
What is the role of prostate-specific antigen (PSA) screening in prostate cancer? An expert panel pr...
What is the role of prostate-specific antigen (PSA) screening in prostate cancer? An expert panel pr...
Whether to screen for prostate cancer in aging men is a topic that is fairly well researched, but re...
Whether to screen for prostate cancer in aging men is a topic that is fairly well researched, but re...
Introducing screening for prostate cancer requires evidence that this would do more good than harm. ...
What is the role of prostate-specific antigen (PSA) screening in prostate cancer? An expert panel pr...
OBJECTIVES: To review evidence regarding the potential introduction of prostate cancer screening pro...
men. It rarely causes death in men younger than 50 years; most deaths associated with it occur in me...
Background Prostate-specific antigen (PSA) remains as the most used biomarker in the detection of ea...
In 2009, the American Cancer Society (ACS) Prostate Cancer Advisory Committee began the process of a...
Since 2012, multiple new guidelines have been issued advising changes in screening for prostate canc...
Objective To investigate the efficacy and safety of prostate-specific antigen (PSA) testing to scree...
Since the early 1990s, many variants of the tPSA assay have been introduced to increase the sensitiv...
OBJECTIVES: To develop clinical guidelines for the management of patients with prostate cancer. MET...
What is the role of prostate-specific antigen (PSA) screening in prostate cancer? An expert panel pr...
What is the role of prostate-specific antigen (PSA) screening in prostate cancer? An expert panel pr...
What is the role of prostate-specific antigen (PSA) screening in prostate cancer? An expert panel pr...
Whether to screen for prostate cancer in aging men is a topic that is fairly well researched, but re...
Whether to screen for prostate cancer in aging men is a topic that is fairly well researched, but re...
Introducing screening for prostate cancer requires evidence that this would do more good than harm. ...
What is the role of prostate-specific antigen (PSA) screening in prostate cancer? An expert panel pr...